A red-hot anti-aging strategy quietly passed its first test earlier this year after 14 volunteers took drugs meant to kill off old, toxic cells in their bodies.
The small study in people with lung disease, reported in January, is being billed as the first attempt at “senolytics,” or employing drugs to clear people’s bodies of aged, toxic cells. Some researchers think this strategy could eventually be employed in healthy people to delay aging.
“This gives us to some extent a green light to go on to larger trials,” says James Kirkland, a Mayo Clinic professor who helped lead the trial, carried out in clinics in Texas and at Wake Forest University starting in 2016.
Patients took two pills that Kirkland and his colleagues believed could selectively get rid of aged cells: the leukemia drug dasatinib and a supplement called quercetin.
It is early days for drugs meant to slow aging, and some breathed a sigh of relief that patients in this first-of-a-kind study didn’t suffer serious side-effects from the drugs. “My worry is we should not leap into this too fast, because if there’s a mistake or something we don’t understand, it could set the field back,” says Judith Campisi, a professor at the Buck Institute for Research on Aging in Novato, California.
This was a pilot trial—not even in the first phase of a three-part sequence of trials needed to win approval by the US Food and Drug Administration. So, officially, it showed nothing about aging at all.
All 14 patients suffered from a fatal, hard-to-treat lung condition called idiopathic pulmonary fibrosis, which explains why they were willing to participate in the experiment. The doctors found that nine doses of the two pills over three weeks did seem to improve patients’ ability to walk a bit farther in the same amount of time, and several other measures of well-being.
A bubble of commercial enthusiasm has been building around the idea that aging could be postponed, or its effects tempered, using drug treatments. A company called Unity Biotechnology of Brisbane, California, is developing two senolytic drugs, the first of which is in a phase 1 clinical trial for osteoarthritis—it’s being injected into people’s knees. Campisi is a cofounder of Unity, and Kirkland also holds shares in the public company, which is currently worth about half a billion dollars.
Image Credit: James Kirkland, Mayo Clinic professor. Mayo Clinic
News This Week
From the moment you turn off your morning alarm, to the time you hit the pillow, your life is full of surfaces. Swiping through your phone, opening doors, putting in your PIN – there are [...]
A new report suggests that lingering “brain fog” and other neurological symptoms after COVID -19 recovery may be due to post-traumatic stress disorder (PTSD), an effect observed in past human coronavirus outbreaks such as SARS [...]
ClSARS-CoV-2, the virus that causes COVID-19, can relieve pain, according to a new study by University of Arizona Health Sciences researchers. The finding may explain why nearly half of people who get COVID-19 [...]
Contrary to president Donald Trump’s repeated declarations, the coronavirus pandemic was not — and still isn’t — totally under control. That lie is central to “Totally Under Control,” the [...]
Summary: A new study suggests COVID-19 may deplete testosterone levels in males. Findings reveal as testosterone decreased, the severity of coronavirus increased. Men who died from coronavirus infection had significantly lower mean testosterone than those [...]
It is the question scientists around the world are trying to answer: how long can the coronavirus survive in the tiny aerosol particles we exhale? In a high-security lab near Bristol, entered through a series [...]
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the [...]
A research team in Hungary pinched the coronavirus with a fine needle to measure how much force it could take before popping like a balloon. It did not. The native virion of Sars-CoV-2 – a [...]
Headaches, confusion and delirium experienced by some Covid-19 patients could be the result of the coronavirus directly invading the brain, according to a study published Wednesday. The research is still preliminary – but offers several [...]
By Boris M | Published in Coronavirus During the COVID-19 pandemic, there will be a lot of information about the virus and its effects on mental health. That’s because coronavirus and the social, financial and psychological [...]
A serious illness suffered by an Oxford University coronavirus vaccine trial participant was most likely “life-threatening”, a bioethics researcher says. But that doesn’t mean the clinical trials will be scrapped. AstraZeneca and Oxford University [...]
Analysis of seven trials finds dexamethasone and hydrocortisone should be given in severe cases. Studies around the world have confirmed that steroids can save lives in the Covid-19 pandemic, leading to new recommendations from [...]
Experts say strong evidence of efficacy needed to avoid approval of inferior vaccines. The rush to immunise populations against Covid-19 could lead to the rollout of a vaccine that is not very effective and [...]
The COVID-19 pandemic has dominated the news cycle for the better part of 2020. As guidelines are continually updated to reflect changes in our understanding of how the virus spreads, it is critical people [...]